CAR-T therapy involves engineering T cells to recognize cancer-specific antigens, enabling targeted killing of malignant cells. Unlike chemotherapy or radiation, it offers a personalized approach, reducing damage to healthy tissues while significantly improving long-term outcomes for patients battling aggressive cancers. https://www.xelleratherapeutics.com/services/custom-manufacturing-services/